Laboratorio Reig Jofre S.A
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables … Read more
Laboratorio Reig Jofre S.A (RJF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.056x
Based on the latest financial reports, Laboratorio Reig Jofre S.A (RJF) has a cash flow conversion efficiency ratio of 0.056x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€11.35 Million) by net assets (€202.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Laboratorio Reig Jofre S.A - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Laboratorio Reig Jofre S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Laboratorio Reig Jofre S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratorio Reig Jofre S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AB VILKUSKIU PIEN.EO 029
F:UDW
|
N/A |
|
Bright Led Electronics Corp
TW:3031
|
0.034x |
|
Sera Prognostics Inc
NASDAQ:SERA
|
-0.079x |
|
Inspirato Inc
NASDAQ:ISPO
|
0.016x |
|
Tofu Restaurant Co Ltd
TWO:2752
|
0.148x |
|
Besiktas Futbol Yatirimlari Sanayi ve Ticaret AS
IS:BJKAS
|
-0.239x |
|
Golden Biotechnology Corporation
TWO:4132
|
-0.282x |
|
KIRAC GALVANIZ
IS:TCKRC
|
0.000x |
Annual Cash Flow Conversion Efficiency for Laboratorio Reig Jofre S.A (2005–2024)
The table below shows the annual cash flow conversion efficiency of Laboratorio Reig Jofre S.A from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €213.95 Million | €31.34 Million | 0.146x | +56.52% |
| 2023-12-31 | €204.25 Million | €19.11 Million | 0.094x | +12.76% |
| 2022-12-31 | €194.55 Million | €16.15 Million | 0.083x | +7.92% |
| 2021-12-31 | €188.51 Million | €14.50 Million | 0.077x | -36.96% |
| 2020-12-31 | €184.48 Million | €22.50 Million | 0.122x | +86.07% |
| 2019-12-31 | €178.14 Million | €11.68 Million | 0.066x | -33.51% |
| 2018-12-31 | €149.74 Million | €14.77 Million | 0.099x | -32.54% |
| 2017-12-31 | €141.56 Million | €20.69 Million | 0.146x | +1407.90% |
| 2016-12-31 | €133.29 Million | €-1.49 Million | -0.011x | -110.96% |
| 2015-12-31 | €126.17 Million | €12.87 Million | 0.102x | +464.70% |
| 2014-12-31 | €118.17 Million | €-3.31 Million | -0.028x | -110.13% |
| 2014-09-30 | €44.70 Million | €12.34 Million | 0.276x | +5171.62% |
| 2013-12-31 | €75.62 Million | €396.00K | 0.005x | +107.71% |
| 2012-12-31 | €86.75 Million | €-5.89 Million | -0.068x | +17.29% |
| 2011-12-31 | €86.59 Million | €-7.11 Million | -0.082x | -19.89% |
| 2010-12-31 | €73.35 Million | €-5.02 Million | -0.068x | +72.68% |
| 2009-12-31 | €93.59 Million | €-23.46 Million | -0.251x | -284.90% |
| 2008-12-31 | €131.95 Million | €17.89 Million | 0.136x | -39.48% |
| 2007-12-31 | €140.91 Million | €31.57 Million | 0.224x | +384.08% |
| 2006-12-31 | €147.74 Million | €6.84 Million | 0.046x | +135.58% |
| 2005-12-31 | €79.25 Million | €-10.31 Million | -0.130x | -- |